Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Using extracellular matrix-derived peptides to alter the microenvironment for myocardial repair.

Mihardja SS, Lee RJ.

Curr Vasc Pharmacol. 2012 May;10(3):342-6. Review.

PMID:
22239636
2.

Extracellular matrix-derived peptides and myocardial repair.

Mihardja SS, Yu J, Lee RJ.

Cell Adh Migr. 2011 Mar-Apr;5(2):111-3.

3.

Myocardial repair: from salvage to tissue reconstruction.

Ruvinov E, Dvir T, Leor J, Cohen S.

Expert Rev Cardiovasc Ther. 2008 Jun;6(5):669-86. doi: 10.1586/14779072.6.5.669. Review.

PMID:
18510484
4.

Targeted in vivo extracellular matrix formation promotes neovascularization in a rodent model of myocardial infarction.

Mihardja SS, Gao D, Sievers RE, Fang Q, Feng J, Wang J, Vanbrocklin HF, Larrick JW, Huang M, Dae M, Lee RJ.

PLoS One. 2010 Apr 28;5(4):e10384. doi: 10.1371/journal.pone.0010384.

5.

The inflammatory response in myocardial infarction.

Frangogiannis NG, Smith CW, Entman ML.

Cardiovasc Res. 2002 Jan;53(1):31-47. Review.

6.

Tissue engineering and stem cell therapy for myocardial repair.

Gu Y, Yu J, Lum LG, Lee RJ.

Front Biosci. 2007 Sep 1;12:5157-65. Review.

PMID:
17569637
7.

Renovation of the injured heart with myocardial tissue engineering.

Leor J, Landa N, Cohen S.

Expert Rev Cardiovasc Ther. 2006 Mar;4(2):239-52. Review.

PMID:
16509819
8.

Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.

Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S.

J Cardiovasc Pharmacol. 2009 Dec;54(6):510-9. doi: 10.1097/FJC.0b013e3181bfac02.

PMID:
19755919
9.

Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo.

Ito Y, Ito K, Shiroto T, Tsuburaya R, Yi GJ, Takeda M, Fukumoto Y, Yasuda S, Shimokawa H.

Coron Artery Dis. 2010 Aug;21(5):304-11.

PMID:
20617568
10.

Extracellular matrix remodeling in canine and mouse myocardial infarcts.

Dobaczewski M, Bujak M, Zymek P, Ren G, Entman ML, Frangogiannis NG.

Cell Tissue Res. 2006 Jun;324(3):475-88.

PMID:
16496177
11.

Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction.

Zhao ZQ, Puskas JD, Xu D, Wang NP, Mosunjac M, Guyton RA, Vinten-Johansen J, Matheny R.

J Am Coll Cardiol. 2010 Mar 23;55(12):1250-61. doi: 10.1016/j.jacc.2009.10.049.

12.

Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction.

Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, Bongartz LG, Peters JH, Hoefer IE, Doevendans PA, Pasterkamp G, de Kleijn DP.

Circ Res. 2011 Mar 4;108(5):582-92. doi: 10.1161/CIRCRESAHA.110.224428.

13.

Mesothelial cell transplantation in myocardial infarction.

Elmadbouh I, Michel JB, Chachques JC.

Int J Artif Organs. 2007 Jun;30(6):541-9. Review.

PMID:
17628855
14.

Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature.

Lauten A, Majos E, Mühlich A, Wahlers T, Weider S, Fischer JH, Figulla HR, Bloch W.

Basic Res Cardiol. 2009 Sep;104(5):559-69. doi: 10.1007/s00395-009-0013-7.

PMID:
19255800
15.

Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.

Cleutjens JP, Creemers EE.

J Card Fail. 2002 Dec;8(6 Suppl):S344-8.

PMID:
12555143
16.

Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts.

Sekine H, Shimizu T, Hobo K, Sekiya S, Yang J, Yamato M, Kurosawa H, Kobayashi E, Okano T.

Circulation. 2008 Sep 30;118(14 Suppl):S145-52. doi: 10.1161/CIRCULATIONAHA.107.757286.

17.

The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice.

Ziegler M, Elvers M, Baumer Y, Leder C, Ochmann C, Schönberger T, Jürgens T, Geisler T, Schlosshauer B, Lunov O, Engelhardt S, Simmet T, Gawaz M.

Circulation. 2012 Feb 7;125(5):685-96. doi: 10.1161/CIRCULATIONAHA.111.070508.

18.

Combination of CD34-positive cell subsets with infarcted myocardium-like matrix stiffness: a potential solution to cell-based cardiac repair.

Zhang S, Ma X, Yao K, Zhu H, Huang Z, Shen L, Qian J, Zou Y, Sun A, Ge J.

J Cell Mol Med. 2014 Jun;18(6):1236-8. doi: 10.1111/jcmm.12301.

19.

RevaTen platelet-rich plasma improves cardiac function after myocardial injury.

Mishra A, Velotta J, Brinton TJ, Wang X, Chang S, Palmer O, Sheikh A, Chung J, Yang PC, Robbins R, Fischbein M.

Cardiovasc Revasc Med. 2011 May-Jun;12(3):158-63. doi: 10.1016/j.carrev.2010.08.005.

PMID:
21122486
20.

Microvascularization and ventricular function after local alginate-encapsulated angiogenic growth factor treatment in a rat cryothermia-induced myocardial infarction model.

Huwer H, Winning J, Vollmar B, Rissland J, Welter C, Schäfers HJ, Menger MD.

Microvasc Res. 2001 Sep;62(2):211-4. No abstract available.

PMID:
11516252
Items per page

Supplemental Content

Support Center